138 related articles for article (PubMed ID: 8037585)
21. Amplification of oncogenes in lung carcinoma grafted in nude mice.
Chauvin C; Jacrot M; Riondel J; Brambilla E; Foote AM; Brambilla C; Benabid AL
Anticancer Res; 1989; 9(2):449-52. PubMed ID: 2568771
[TBL] [Abstract][Full Text] [Related]
22. c-myc antisense oligodeoxyribonucleotides inhibit proliferation of non-small cell lung cancer.
Robinson LA; Smith LJ; Fontaine MP; Kay HD; Mountjoy CP; Pirruccello SJ
Ann Thorac Surg; 1995 Dec; 60(6):1583-91. PubMed ID: 8787447
[TBL] [Abstract][Full Text] [Related]
23. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids.
Pelosi G; Scarpa A; Puppa G; Veronesi G; Spaggiari L; Pasini F; Maisonneuve P; Iannucci A; Arrigoni G; Viale G
Cancer; 2005 Mar; 103(6):1154-64. PubMed ID: 15712207
[TBL] [Abstract][Full Text] [Related]
24. Amplification of the c-myc oncogene in a subpopulation of human small cell lung cancer.
Saksela K; Bergh J; Lehto VP; Nilsson K; Alitalo K
Cancer Res; 1985 Apr; 45(4):1823-7. PubMed ID: 2983887
[TBL] [Abstract][Full Text] [Related]
25. [Clinicopathological study on primary lung cancer--immunohistochemical expression of p53 suppressor gene and bcl-2 oncogene in relation to prognosis].
Irie K; Ishida H; Furukawa T; Koyanagi K; Miyamoto Y
Rinsho Byori; 1996 Jan; 44(1):32-41. PubMed ID: 8691638
[TBL] [Abstract][Full Text] [Related]
26. Effects of c-myc oncogene modulation on differentiation of human small cell lung carcinoma cell lines.
van Waardenburg RC; Meijer C; Pinto-Sietsma SJ; de Vries EG; Timens W; Mulder NM
Anticancer Res; 1998; 18(1A):91-5. PubMed ID: 9568061
[TBL] [Abstract][Full Text] [Related]
27. [Expression of oncogenes C-myc, C-raf and N-ras in advanced cancers of the upper respiratory and digestive tracts. Correlation with tumor clinical response to chemotherapy].
Reyt E; Lavieille JP; Brambilla E; Barra Y; Riva C
Ann Otolaryngol Chir Cervicofac; 1993; 110(6):310-5. PubMed ID: 8210089
[TBL] [Abstract][Full Text] [Related]
28. The myc family of oncogenes and their presence and importance in small-cell lung carcinoma and other tumour types.
Prins J; De Vries EG; Mulder NH
Anticancer Res; 1993; 13(5A):1373-85. PubMed ID: 8239508
[TBL] [Abstract][Full Text] [Related]
29. Value of glutathione S-transferase pi and the oncogene products c-Jun, c-Fos, c-H-Ras, and c-Myc as a prognostic indicator in endometrial carcinomas.
Yokoyama Y; Sagara M; Sato S; Saito Y
Gynecol Oncol; 1998 Mar; 68(3):280-7. PubMed ID: 9570981
[TBL] [Abstract][Full Text] [Related]
30. Oncogene and HSP-70 expression in primary tumor cell cultures of renal cell carcinoma compared to their corresponding cell line.
Köhler G; Veelken H; Rosenthal F; Mackensen A; Lindemann A; Schaefer HE; Lahn M
Anticancer Res; 1997; 17(5A):3225-31. PubMed ID: 9413152
[TBL] [Abstract][Full Text] [Related]
31. Quantitative expansion of structural genomic alterations in the spectrum of neuroendocrine lung carcinomas.
Gugger M; Burckhardt E; Kappeler A; Hirsiger H; Laissue JA; Mazzucchelli L
J Pathol; 2002 Apr; 196(4):408-15. PubMed ID: 11920736
[TBL] [Abstract][Full Text] [Related]
32. Heterogeneous immunoreactivity of frozen human benign and malignant breast lesions to C-MYC and C-Ha-ras cellular oncogenes.
Pechoux C; Chardonnet Y; Chignol MC; Noël P
Histol Histopathol; 1994 Jan; 9(1):35-44. PubMed ID: 8003818
[TBL] [Abstract][Full Text] [Related]
33. All-trans-retinoic acid alters myc gene expression and inhibits in vitro progression in small cell lung cancer.
Kalemkerian GP; Jasti RK; Celano P; Nelkin BD; Mabry M
Cell Growth Differ; 1994 Jan; 5(1):55-60. PubMed ID: 8123593
[TBL] [Abstract][Full Text] [Related]
34. Mechanism of all-trans-retinoic acid-mediated L-myc gene regulation in small cell lung cancer.
Ou X; Campau S; Slusher R; Jasti RK; Mabry M; Kalemkerian GP
Oncogene; 1996 Nov; 13(9):1893-9. PubMed ID: 8934535
[TBL] [Abstract][Full Text] [Related]
35. [Clinicopathological significance of expression of c-kit protein in neuroendocrine lung carcinoma].
Zhao P; Hou N; Shao Y; Li XH
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(22):1526-9. PubMed ID: 16179109
[TBL] [Abstract][Full Text] [Related]
36. [Small cell carcinoma and carcinoids of the lung: morphology of apoptosis and expression of biomolecular markers of tumor growth].
Pal'tsev MA; Demura SA; Kogan EA; Jack G; Zende B
Arkh Patol; 2000; 62(5):11-7. PubMed ID: 11076293
[TBL] [Abstract][Full Text] [Related]
37. Modulation of c-myc, c-myb, c-fos, c-sis and c-fms proto-oncogene expression and of CSF-1 transcripts and protein by phorbol diester in human malignant histiocytosis DEL cell line with 5q 35 break point.
Gogusev J; Barbey S; Nezelof C
Anticancer Res; 1993; 13(4):1043-7. PubMed ID: 8352523
[TBL] [Abstract][Full Text] [Related]
38. [Detection of H-ras and K-ras in tumors of gastrointestinal-pancreatic system].
Liedke M; Karnbach C; Kalinin V; Herbst B; Frilling A; Broelsch CE
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):255-9. PubMed ID: 14518255
[TBL] [Abstract][Full Text] [Related]
39. Dual role of RASSF1 as a tumor suppressor and an oncogene in neuroendocrine tumors of the lung.
Pelosi G; Fumagalli C; Trubia M; Sonzogni A; Rekhtman N; Maisonneuve P; Galetta D; Spaggiari L; Veronesi G; Scarpa A; Malpeli G; Viale G
Anticancer Res; 2010 Oct; 30(10):4269-81. PubMed ID: 21036752
[TBL] [Abstract][Full Text] [Related]
40. [Immunohistochemistry of biomolecular markers of lung cancer].
Kogan EA; Zhak G; Kaĭzer U; Shilli M; Shurman M; Sherer A; Khavemann K
Arkh Patol; 1997; 59(6):23-30. PubMed ID: 9483214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
